Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis

Abstract Background After coronavirus disease 2019 (COVID-19) shelter-in-place (SIP) orders, viral suppression (VS) rates initially decreased within a safety-net human immunodeficiency virus (HIV) clinic in San Francisco, particularly among people living with HIV (PLWH) who are experiencing homelessness. We sought to determine if proactive outreach to provide social services, scaling up of in-person visits, and expansion of housing programs could reverse this decline. Methods We assessed VS 24 months before and 13 months after SIP using mixed-effects logistic regression followed by interrupted time series (ITS) analysis to examine changes in the rate of VS per month. Loss to follow-up (LTFU) was assessed via active clinic tracing. Results Data from 1816 patients were included; the median age was 51 years, 12% were female, and 14% were experiencing unstable housing/homelessness. The adjusted odds of VS increased 1.34 fold following institution of the multicomponent strategies (95% confidence interval [CI], 1.21–1.46). In the ITS analysis, the odds of VS continuously increased 1.05 fold per month over the post-intervention period (95% CI, 1.01–1.08). Among PLWH who previously experienced homelessness and successfully received housing support, the odds of VS were 1.94-fold higher (95% CI, 1.05–3.59). The 1-year LTFU rate was 2.8 per 100 person-years (95% CI, 2.2–3.5). Conclusions The VS rate increased following institution of the multicomponent strategies, with a lower LFTU rate compared with prior years. Maintaining in-person care for underserved patients, with flexible telemedicine options, along with provision of social services and permanent expansion of housing programs, will be needed to support VS among underserved populations during the COVID-19 pandemic.

[1]  V. Vannappagari,et al.  886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US , 2021, Open Forum Infectious Diseases.

[2]  V. Marconi,et al.  Patient Experiences with Telemedicine for HIV Care during the first COVID-19 Wave in Atlanta, Georgia. , 2021, AIDS research and human retroviruses.

[3]  H. N. Kim,et al.  Visit Trends and Factors Associated With Telemedicine Uptake Among Persons With HIV During the COVID-19 Pandemic , 2021, Open forum infectious diseases.

[4]  A. Giacomelli,et al.  Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic , 2021, Journal of acquired immune deficiency syndromes.

[5]  F. Castelli,et al.  Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy , 2021, AIDS Research and Therapy.

[6]  M. Peluso,et al.  SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study , 2021, The Lancet HIV.

[7]  Maria Sorbera,et al.  Evaluation of virologic suppression rates during the COVID‐19 pandemic with outpatient interdisciplinary HIV care , 2021, Journal of the American College of Clinical Pharmacy : JACCP.

[8]  J. Fuchs,et al.  Assessment of a Hotel-Based COVID-19 Isolation and Quarantine Strategy for Persons Experiencing Homelessness , 2021, JAMA network open.

[9]  Brian R Wood,et al.  The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future , 2021, Current HIV/AIDS Reports.

[10]  L. Geidelberg,et al.  The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study , 2021, The Lancet HIV.

[11]  J. Hoy,et al.  The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia. , 2021, AIDS research and human retroviruses.

[12]  D. Havlir,et al.  Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing. , 2021, AIDS.

[13]  S. Swindells,et al.  A Midwestern Academic HIV Clinic Operation during the COVID-19 Pandemic: Implementation Strategy and Preliminary Outcomes , 2021, Journal of the International Association of Providers of AIDS Care.

[14]  Jan Bing Del Rosario,et al.  Viral suppression during COVID-19 among people with HIV experiencing homelessness in a low-barrier clinic-based program , 2020, AIDS.

[15]  Brian R Wood,et al.  Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Glidden,et al.  Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. , 2020, AIDS.

[17]  M. Gandhi,et al.  Coronavirus Disease 2019 (COVID-19) and HIV Spotlight the United States Imperative for Permanent Affordable Housing , 2020, Clinical Infectious Diseases.

[18]  R. Glaubius,et al.  Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models , 2020, The lancet. HIV.

[19]  P. Chan,et al.  Development of Telemedicine Infrastructure at an LGBTQ+ Clinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI , 2020, AIDS and Behavior.

[20]  E. Vittinghoff,et al.  Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System , 2019, Journal of General Internal Medicine.

[21]  S. Buchbinder,et al.  Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a U.S. City. , 2019, AIDS.

[22]  J. Bamberger,et al.  Difference in Survival between Housed and Homeless individuals with HIV, San Francisco, 2002–2011 , 2015, Journal of health care for the poor and underserved.

[23]  Evangelos Kontopantelis,et al.  Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis , 2015, BMJ : British Medical Journal.

[24]  Wayne T. Steward,et al.  Examining Clinic-Based and Public Health Approaches to Ascertainment of HIV Care Status , 2015, Journal of acquired immune deficiency syndromes.

[25]  Paul T. von Hippel,et al.  New Confidence Intervals and Bias Comparisons Show That Maximum Likelihood Can Beat Multiple Imputation in Small Samples , 2013, 1307.5875.

[26]  E. Vittinghoff,et al.  Impact of housing on the survival of persons with AIDS , 2009, BMC public health.

[27]  R. Kee,et al.  The health impact of supportive housing for HIV-positive homeless patients: a randomized controlled trial. , 2009, American journal of public health.